BPMC
T. Rowe Price Associates’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188M | Sell |
1,464,968
-3,950,869
| -73% | -$506M | 0.02% | 443 |
|
|
2025
Q1 | $479M | Sell |
5,415,837
-263,252
| -5% | -$23.3M | 0.06% | 276 |
|
|
2024
Q4 | $495M | Buy |
5,679,089
+291,822
| +5% | +$25.5M | 0.06% | 271 |
|
|
2024
Q3 | $498M | Sell |
5,387,267
-486,125
| -8% | -$45M | 0.06% | 278 |
|
|
2024
Q2 | $633M | Sell |
5,873,392
-377,431
| -6% | -$40.7M | 0.08% | 226 |
|
|
2024
Q1 | $593M | Buy |
6,250,823
+821,868
| +15% | +$78M | 0.07% | 250 |
|
|
2023
Q4 | $501M | Sell |
5,428,955
-67,622
| -1% | -$6.24M | 0.07% | 257 |
|
|
2023
Q3 | $276M | Sell |
5,496,577
-126,799
| -2% | -$6.37M | 0.04% | 329 |
|
|
2023
Q2 | $355M | Buy |
5,623,376
+674,942
| +14% | +$42.7M | 0.05% | 291 |
|
|
2023
Q1 | $223M | Buy |
4,948,434
+649,144
| +15% | +$29.2M | 0.03% | 358 |
|
|
2022
Q4 | $188M | Buy |
4,299,290
+267,479
| +7% | +$11.7M | 0.03% | 390 |
|
|
2022
Q3 | $266M | Sell |
4,031,811
-1,599,876
| -28% | -$105M | 0.04% | 317 |
|
|
2022
Q2 | $284M | Buy |
5,631,687
+698,562
| +14% | +$35.3M | 0.04% | 387 |
|
|
2022
Q1 | $315M | Buy |
4,933,125
+382,586
| +8% | +$24.4M | 0.03% | 418 |
|
|
2021
Q4 | $487M | Buy |
4,550,539
+178,711
| +4% | +$19.1M | 0.04% | 358 |
|
|
2021
Q3 | $449M | Buy |
4,371,828
+109,714
| +3% | +$11.3M | 0.04% | 365 |
|
|
2021
Q2 | $375M | Buy |
4,262,114
+212,840
| +5% | +$18.7M | 0.03% | 398 |
|
|
2021
Q1 | $394M | Buy |
4,049,274
+361,508
| +10% | +$35.1M | 0.04% | 379 |
|
|
2020
Q4 | $414M | Buy |
3,687,766
+121,360
| +3% | +$13.6M | 0.04% | 367 |
|
|
2020
Q3 | $331M | Sell |
3,566,406
-23,478
| -0.7% | -$2.18M | 0.04% | 375 |
|
|
2020
Q2 | $280M | Buy |
3,589,884
+3,793
| +0.1% | +$296K | 0.04% | 400 |
|
|
2020
Q1 | $210M | Buy |
3,586,091
+232,524
| +7% | +$13.6M | 0.03% | 397 |
|
|
2019
Q4 | $269M | Sell |
3,353,567
-257,646
| -7% | -$20.6M | 0.03% | 417 |
|
|
2019
Q3 | $265M | Sell |
3,611,213
-70,078
| -2% | -$5.15M | 0.04% | 391 |
|
|
2019
Q2 | $347M | Buy |
3,681,291
+305,682
| +9% | +$28.8M | 0.05% | 344 |
|
|
2019
Q1 | $270M | Buy |
3,375,609
+353,502
| +12% | +$28.3M | 0.04% | 388 |
|
|
2018
Q4 | $163M | Buy |
3,022,107
+137,760
| +5% | +$7.43M | 0.03% | 491 |
|
|
2018
Q3 | $225M | Sell |
2,884,347
-237,971
| -8% | -$18.6M | 0.03% | 456 |
|
|
2018
Q2 | $198M | Sell |
3,122,318
-346,249
| -10% | -$22M | 0.03% | 482 |
|
|
2018
Q1 | $318M | Buy |
3,468,567
+159,165
| +5% | +$14.6M | 0.05% | 354 |
|
|
2017
Q4 | $250M | Buy |
3,309,402
+562,244
| +20% | +$42.4M | 0.04% | 413 |
|
|
2017
Q3 | $191M | Buy |
2,747,158
+273,173
| +11% | +$19M | 0.03% | 454 |
|
|
2017
Q2 | $125M | Buy |
2,473,985
+459,336
| +23% | +$23.3M | 0.02% | 538 |
|
|
2017
Q1 | $80.6M | Buy |
2,014,649
+1,275,147
| +172% | +$51M | 0.02% | 655 |
|
|
2016
Q4 | $20.7M | Buy |
739,502
+386,308
| +109% | +$10.8M | ﹤0.01% | 1130 |
|
|
2016
Q3 | $10.5M | Sell |
353,194
-241,789
| -41% | -$7.18M | ﹤0.01% | 1305 |
|
|
2016
Q2 | $12M | Buy |
594,983
+83,175
| +16% | +$1.68M | ﹤0.01% | 1250 |
|
|
2016
Q1 | $9.24M | Sell |
511,808
-22,040
| -4% | -$398K | ﹤0.01% | 1290 |
|
|
2015
Q4 | $14.1M | Buy |
533,848
+35,699
| +7% | +$940K | ﹤0.01% | 1195 |
|
|
2015
Q3 | $10.6M | Sell |
498,149
-5,401
| -1% | -$115K | ﹤0.01% | 1291 |
|
|
2015
Q2 | $13.3M | Buy |
+503,550
| New | +$13.3M | ﹤0.01% | 1266 |
|